投資評等
最後更新日期：2024/11/16
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2015/7/31 | UBS | Sell >> Neutral | $30.50 >> $33 |
| 2014/11/5 | Pivotal Research Group | Hold >> Buy | $40 >> $39 |
| 2010/1/15 | JP Morgan | Neutral >> Overweight | $26 >> $35 |
| 2008/11/21 | Matrix Research | Buy Strong Buy | |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2015/10/16 | Barclays | Overweight >> Equal Weight | $34 >> $30 |
| 2015/10/14 | Macquarie | Outperform >> Neutral | |
| 2012/5/14 | Barrington Research | Outperform >> Mkt Perform | |
| 2011/10/26 | MKM Partners | Buy >> Neutral | |
| 2011/6/23 | UBS | Buy >> Neutral | |
| 2010/11/3 | Barrington Research | Outperform >> Mkt Perform | |
| 2010/9/7 | Caris & Company | Above Average >> Average | |
| 2010/2/23 | Barclays Capital | Overweight >> Equal Weight | 30 |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2014/7/9 | Barclays | Overweight | 87 |
| 2010/4/21 | MKM Partners | Buy | 41 |
| 2010/1/12 | Caris & Company | Above Average | 38 |
| 2009/9/9 | Oppenheimer | Outperform | 31 |
| 2009/7/30 | Piper Jaffray | Overweight | 30 |
| 2009/6/30 | Barrington Research | Outperform | 27 |
| 2009/4/8 | Jefferies & Co | Hold | 18 |
| 2009/3/24 | Bernstein | Mkt Perform | |
| 2008/12/18 | UBS | Neutral | 14 |
| 2005/9/8 | Jefferies Co | Buy | 18.5 |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 查無資料 | | | |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2014/11/4 | MKM Partners | Neutral | $41 >> $36 |
| 2014/8/21 | Barclays | Overweight | $87 >> $48 |
| 2012/11/7 | MKM Partners | Neutral | $64 >> $62 |
| 2012/10/23 | RBC Capital Mkts | Outperform | $55 >> $62 |
| 2010/11/2 | MKM Partners | Buy | $43 >> $50 |
| 2010/10/15 | Deutsche Bank | Buy | $49 >> $52 |
| 2010/5/3 | RBC Capital Mkts | Outperform | $37 >> $41 |
| 2009/4/23 | RBC Capital Mkts | Outperform | |
| 2007/6/7 | Pali Research | Buy | |